BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Semaglutide: trial readouts and FDA decisions

3 upcoming industry Phase 2/3 readout(s) in the next 90 days, 0 upcoming FDA event(s), 9 readout(s) in the last 180 days and 0 FDA event(s) in the last 12 months. Sponsors: Novo Nordisk A/S, Skye Bioscience, Inc., Guangdong Raynovent Biotech Co., Ltd, Innovent Biologics (Suzhou) Co. Ltd., Eccogene, Gan & Lee Pharmaceuticals., Eli Lilly and Company, Fujian Shengdi Pharmaceutical Co., Ltd.. Drug names come from ClinicalTrials.gov intervention names and FDA records, lightly normalised; one drug can appear under several names (code, generic, brand).

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-11-20 est.P2Skye Bioscience, Inc. SKYENCT06577090 Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs PlaceboObesityactive not recruiting136
2026-12-01 est.P3Guangdong Raynovent Biotech Co., LtdNCT07139548 A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 DiabetesT2DMnot yet recruiting600
2026-12-31 est.P3Innovent Biologics (Suzhou) Co. Ltd.NCT06884293 A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Overweight; Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)active not recruiting479

Readouts, last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-10-15 est.P2EccogeneNCT07505303 MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) TrialAdult Obesity; Weight Managementactive not recruiting151
2026-09-18P3Gan & Lee Pharmaceuticals.NCT06778967 A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)completed1133
2026-09-01 est.P2Novo Nordisk A/S NVONCT06717698 A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseChronic Kidney Diseaserecruiting465
2026-08-27P3Eli Lilly and Company LLYNCT06260722 Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Diabetes Mellitus, Type 2active not recruiting1250
2026-07-18P3Fujian Shengdi Pharmaceutical Co., Ltd.NCT06649344 A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2Type 2 Diabetescompleted884
2026-06-29P3Novo Nordisk A/S NVONCT07271251 A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People WiType 2 Diabetescompleted267
2026-06-16P2Regeneron Pharmaceuticals REGNNCT06299098 A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for WeigObesitycompleted1005
2026-06-02P3Novo Nordisk A/S NVONCT06534411 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLDiabetes Mellitus, Type 2completed1023
2026-05-30 est.P3Hangzhou Jiuyuan Gene Engineering Co. Ltd.,NCT06633783 A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®Obesityunknown370

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.